Back to Woodline Partners LP Woodline Partners LP

ABCL

9 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in AbCellera Biologics Inc.

No. Woodline Partners exited its ABCL (AbCellera Biologics) position in Q3 2024. Its Q2 2024 13F listed 12,163 shares worth $36,002. Woodline Partners already held ABCL in its Q4 2020 13F, the earliest on record, and held it in 7 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$17.3M

Total Shares Change

-431,087

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q3
Latest
Exited
0
-100.0%
$00.0%$2.61
0
2024-Q2
New
12,163
-
$36,0020.0%$2.96
28
2022-Q2
Exited
0
-100.0%
$00.0%$10.11
0
2022-Q1
Decreased
136,910
-79.6%
$1.3M0.0%$9.75
0
2021-Q4
Increased
670,639
+69.0%
$9.6M0.1%$14.34
49
2021-Q3
Unchanged
396,816
0.0%
$8M0.1%$19.45
0
2021-Q2
Increased
396,816
+55.7%
$8.7M0.2%$22.00
47
2021-Q1
Decreased
254,902
-40.9%
$8.7M0.2%$26.68
0
2020-Q4
New
431,087
-
$17.3M0.5%$41.10
47

Other major holders of ABCL: Viking Global Investors LP, Baker Bros. Advisors LP, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used